20.4 C
New York
Thursday, June 18, 2026

Tag: forms

BrightPath Early Learning and Child Care Celebrates 15 Years of Giving Children the Best Start in Life

Leading Child Care Provider Marks Milestone with a Chance to Win a Full Year of Free Child Care WEST SENECA, N.Y., Aug. 8, 2025 /PRNewswire/...

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

Dr. Wenham is Principal investigator on Anixa's CAR-T therapy for Ovarian Cancer SAN JOSE, Calif., Aug. 8, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or...

THE WENDY’S COMPANY REPORTS SECOND QUARTER 2025 RESULTS

Global systemwide sales were $3.7 billion, a decrease of 1.8%International systemwide sales grew 8.7% with growth across all regionsAdded 26 net new restaurants and...

Net Asset Value(s)

8 August 2025

Net Asset Value(s)

8 August 2025

Lassonde Industries Inc. announces its Q2-2025 results

ROUGEMONT, Québec, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced its financial results for the second quarter of 2025.

ALMORA BOTANICA GRANTED TWO GROUNDBREAKING PATENTS

A New Era of Ayurvedic Skincare Innovation LONDON, Aug. 7, 2025 /PRNewswire/ -- Almora Botanica, the pioneering science-first Ayurvedic skincare brand, has secured two groundbreaking...

Saga Communications, Inc. Reports 2nd Quarter 2025 Results

GROSSE POINTE FARMS, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saga Communications, Inc. (Nasdaq - SGA) (the “Company” or “Saga”) today reported that net revenue decreased 5.0% to $28.2 million for the quarter ended June 30, 2025 compared to $29.7 million for the same period last year. Station operating expense decreased 4.6% for the quarter to $22.2 million compared to the same period last year. For the quarter, operating income was $1.4 million compared to $2.1 million for the same quarter last year and station operating income (a non-GAAP financial measure) decreased 6.4% to $6.0 million. Capital expenditures were $1.3 million for the quarter compared to $1.5 million for the same period last year. We had net income of $1.1 million for the quarter compared to net income of $2.5 million for the second quarter last year. Diluted earnings per share were $0.18 in the second quarter of 2025.

Ascent Solar Technologies Establishes Rapid Thin-Film PV Delivery Process to Provide Customized Space Solar Products Ahead of Schedule on Mission Enabling Timelines

THORNTON, Colo., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (“Ascent” or the “Company”) (Nasdaq: ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, continues to set precedence via its new standard for rapid delivery of space-mission enabling PV products. The Company has now delivered mission-optimized solar array blanket spaceflight hardware assemblies to multiple customers, each in under three weeks from order.

Lilly reports second-quarter 2025 financial results and raises guidance

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. Increased the midpoint of our 2025 full-year...

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.

SIGGRAPH 2025 Ignites Global AI Dialogue Across Art, Science, and Industry

Conference Unites Diverse Disciplines to Explore the Expanding Role of Artificial Intelligence in Creativity, Computation, and Connection. VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ -- From...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsForms